Acumen Pharmaceuticals (ABOS) Revenue & Revenue Breakdown
Acumen Pharmaceuticals Revenue Highlights
00
Acumen Pharmaceuticals Revenue by Period
Acumen Pharmaceuticals Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | -100.00% |
| 2020-12-31 | $1.44M | -15.38% |
| 2019-12-31 | $1.70M | - |
Acumen Pharmaceuticals generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Acumen Pharmaceuticals Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | - | 100.00% |
| 2025-06-30 | - | 100.00% |
| 2025-03-31 | - | -100.00% |
| 2024-12-31 | $178.00K | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $290.00K | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | -100.00% |
| 2020-12-31 | $1.44M | 96.71% |
| 2020-09-30 | $730.00K | 383.44% |
| 2020-06-30 | $151.00K | -33.19% |
| 2020-03-31 | $226.00K | - |
Acumen Pharmaceuticals generated - in revenue during Q3 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Acumen Pharmaceuticals Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| AGEN | Agenus | $103.46M | $30.23M |
| ALEC | Alector | $100.56M | $3.26M |
| SPRO | Spero Therapeutics | $47.98M | $11.80M |
| SEER | Seer | $14.17M | $4.12M |
| FATE | Fate Therapeutics | $13.63M | $1.91M |
| IRD | Opus Genetics | $10.99M | - |
| VTGN | VistaGen Therapeutics | $1.06M | $244.00K |
| ACTU | Actuate Therapeutics | - | - |
| MCRB | Seres Therapeutics | - | $351.00K |
| INO | Inovio Pharmaceuticals | - | - |
| ABOS | Acumen Pharmaceuticals | - | - |